HDAC2 as a target for developing anti-cancer drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HDAC2 as a target for developing anti-cancer drugs

Published:2023 Issue: Volume:21 Page:2048-2057
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Jo Hyein,Shim Kyeonghee,Kim Han-Ul,Jung Hyun Suk,Jeoung Dooil

Funder

Ministry of Health and Welfare

Korea Health Industry Development Institute

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference116 articles.

1. Recent advances in cancer therapeutics;Chessum;Prog Med Chem,2015

2. Interaction of Histone Acetylases and Deacetylases In Vivo

3. Functional significance of histone deacetylase diversity;Khochbin;Curr Opin Genet Dev,2001

4. Trans-regulation of Histone Deacetylase Activities through Acetylation

5. Regulation of histone deacetylase 2 by protein kinase CK2;Tsai;J Biol Chem,2002

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NUCKS1 promotes invasion and metastasis of colorectal cancer by stabilizing HDAC2 and activating AKT;2024-09-10

2. ACAP3 negatively regulated by HDAC2 inhibits the malignant development of papillary thyroid carcinoma cells;The International Journal of Biochemistry & Cell Biology;2024-09

3. Tanshinone IIA potentiates the therapeutic efficacy of glucocorticoid in lipopolysaccharide-treated HEI-OC1 cells through modulation of Foxp3/Nrf2 signaling pathway;2024-08-19

4. Genomic analyses identify 15 susceptibility loci and revealHDAC2,SOX2-OT, andIGF2BP2in a naturally-occurring canine model of gastric cancer;2024-08-16

5. Discovery of a dual-target DYRK2 and HDAC8 inhibitor for the treatment of hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3